Tesamorelin
Potent visceral fat reduction with hormonal GH support.
SC injection — FDA-approved dose for HIV lipodystrophy: 2 mg SC daily; off-label dosing per physician; typically used in cycles with IGF-1 and glucose monitoring
What It Is
Tesamorelin is a GHRH (growth hormone releasing hormone) analog that is FDA-approved for HIV lipodystrophy (visceral fat accumulation). It is used off-label to target visceral fat reduction and raise GH; it is potent for abdominal fat loss and also improves lipid profiles.
Mechanism
Tesamorelin is a GHRH analog FDA-approved for HIV lipodystrophy. It is used off-label to target visceral fat reduction and raise GH. It is potent for abdominal fat loss and also improves lipid profiles. It acts on the pituitary to stimulate GH release, which then raises IGF-1 and promotes lipolysis — particularly in visceral adipose tissue. It is more targeted to fat loss than the CJC-1295/Ipamorelin combo and produces more significant IGF-1 elevation.
How Dr. Emer Uses It
Tesamorelin is particularly used in men with metabolic syndrome (to shrink visceral adiposity) and in fitness enthusiasts prepping for photoshoots to get a bit more abdominal definition. If muscle loss is noted during GLP-1 therapy, adjust diet or add a muscle peptide like Tesamorelin or a low-dose GH secretagogue at night to counter it. Monitoring includes IGF-1 levels, fasting glucose (GH can increase glucose), and body composition scans (DEXA) are tracked.
Key Benefits
- ✓FDA-approved GHRH analog specifically effective for visceral fat reduction
- ✓Raises GH and IGF-1 to promote lipolysis in abdominal adipose tissue
- ✓Improves lipid profiles alongside visceral fat reduction
- ✓Counters muscle loss during aggressive caloric restriction or GLP-1 therapy
- ✓Particularly effective in men with metabolic syndrome for abdominal definition
- ✓Potent anabolic support post-surgery to preserve lean mass during recovery
Pairs Well With
Used In Programs
Safety & Considerations
Monitor IGF-1 levels and fasting glucose (GH can increase glucose). Body composition scans (DEXA) are tracked. Alternatives considered: for those who cannot inject daily, there are oral secretagogues (MK-677 ibutamoren) — EmerGPT can suggest those if adherence is an issue, but with caution toward increased appetite side effect. Women concerned about aging but wary of HGH (which can cause blood sugar issues) also benefit from the gentler secretagogues.
Begin Your RECODEX™ Protocol
All peptide therapies are prescribed under direct medical supervision.
Book a Consultation
